| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/MC.2940130204 |
| P953 | full work available at URL | https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmc.2940130204 |
| https://onlinelibrary.wiley.com/doi/pdf/10.1002/mc.2940130204 | ||
| P698 | PubMed publication ID | 7605583 |
| P2093 | author name string | M. S. Berger | |
| J. R. Silber | |||
| M. S. Bobola | |||
| P2860 | cites work | Expression of human O6-methylguanine-DNA methyltransferase in Chinese hamster ovary cells and restoration of cellular resistance to certain N-nitroso compounds. | Q53502595 |
| Contribution of O6‐methylguanine‐DNA methyltransferase to monofunctional alkylating‐agent resistance in human brain tumor—derived cell lines | Q54171811 | ||
| Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme. | Q54255608 | ||
| Expression in mammalian cells of a truncated Escherichia coli gene coding for O6-alkylguanine alkyltransferase reduces the toxic effects of alkylating agents. | Q54331120 | ||
| Overexpression of metallothionein confers resistance to anticancer drugs. | Q54376480 | ||
| Modulation of mammalian O6-alkylguanine-DNA alkyltransferase in vivo by O6-benzylguanine and its effect on the sensitivity of a human glioma tumor to 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea. | Q55484775 | ||
| Chemotherapy for malignant gliomas | Q68123563 | ||
| Mutagenic and recombinogenic consequences of DNA-repair inhibition during treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea in Saccharomyces cerevisiae | Q68529936 | ||
| Improved plating efficiencies for human tumors cloned in capillary tubes versus Petri dishes | Q69565957 | ||
| Positive correlation between the extent of cell proliferation and the regulation of base excision repair | Q71350045 | ||
| DNA repair | Q72883771 | ||
| Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 | ||
| Checkpoints: controls that ensure the order of cell cycle events | Q28131705 | ||
| Repair of DNA containing O6-alkylguanine | Q28284603 | ||
| Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents | Q33689518 | ||
| Apoptosis induced by anticancer drugs | Q35233723 | ||
| Protection against chloroethylnitrosourea cytotoxicity by eukaryotic 3-methyladenine DNA glycosylase | Q36730360 | ||
| A reduced rate of bulky DNA adduct removal is coincident with differentiation of human neuroblastoma cells induced by nerve growth factor | Q36845830 | ||
| Medulloblastoma: tumor biological and clinical perspectives | Q37386386 | ||
| The regulation of DNA repair during development | Q37925497 | ||
| DNA alkylation by the haloethylnitrosoureas: nature of modifications produced and their enzymatic repair or removal | Q37984292 | ||
| Isolation and purification of O6-alkylguanine-DNA alkyltransferase from human leukemic cells. Prevention of chloroethylnitrosourea-induced cross-links by purified enzyme | Q39844025 | ||
| Chemical mutagenesis | Q40338278 | ||
| Influence of proliferation on DNA repair rates in liver | Q41172577 | ||
| Effect of O6-methylguanine-DNA methyltransferase gene activity on repair in human cells transformed by a regulatable ada gene | Q41750627 | ||
| Efficacy of adjuvant chemotherapy for patients with poor-risk medulloblastoma: a preliminary report | Q44964244 | ||
| Transfection and expression of human O6-methylguanine-DNA methyltransferase (MGMT) cDNA in Chinese hamster cells: the role of MGMT in protection against the genotoxic effects of alkylating agents | Q46067039 | ||
| The effects of O6-benzylguanine and hypoxia on the cytotoxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea in nitrosourea-resistant SF-763 cells | Q46280203 | ||
| Treatment of subcutaneous and intracranial brain tumor xenografts with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea. | Q48379404 | ||
| The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part I: Evaluation of test-specific variables | Q48483676 | ||
| Increased repair of O6-alkylguanine DNA adducts in glioma-derived human cells resistant to the cytotoxic and cytogenetic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea. | Q52834145 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 81-88 | |
| P577 | publication date | 1995-06-01 | |
| P1433 | published in | Molecular Carcinogenesis | Q15724597 |
| P1476 | title | Contribution of O6‐methylguanine‐DNA methyltransferase to resistance to 1,3‐(2‐chloroethyl)‐1‐nitrosourea in human brain tumor‐derived cell lines | |
| P478 | volume | 13 |
| Q54019386 | Altered nuclear localization of bax protein in BCNU-resistant glioma cells. |
| Q73835486 | Anticancer drug resistance in primary human brain tumors |
| Q54171811 | Contribution of O6‐methylguanine‐DNA methyltransferase to monofunctional alkylating‐agent resistance in human brain tumor—derived cell lines |
| Q33699997 | DNA ligase IV as a new molecular target for temozolomide |
| Q39701975 | DNA ligase IV is a potential molecular target in ACNU sensitivity |
| Q38840489 | Investigating a signature of temozolomide resistance in GBM cell lines using metabolomics |
| Q41905507 | Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide |
| Q38350366 | MMR/c-Abl-dependent activation of ING2/p73alpha signaling regulates the cell death response to N-methyl-N'-nitro-N-nitrosoguanidine |
| Q36272990 | New delivery approaches for pediatric brain tumors |
| Q26853112 | O(6)-methylguanine-DNA methyltransferase in glioma therapy: promise and problems |
| Q40336092 | Synthesis and Antitumor Activity Evaluation of a Novel Combi-nitrosourea Prodrug: BGCNU. |
| Q36299167 | The prognostic value of MGMT promoter methylation in glioblastoma: A meta-analysis of clinical trials. |
Search more.